Universal-Beteiligungs- und Servicegesellschaft
KLRA

Universal-Beteiligungs- und Servicegesellschaft’s Kailera Therapeutics KLRA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio KLRA Stock Details KLRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Buy
+22,951
New +$505K ﹤0.01% 1777

Other funds holding KLRA

ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's KLRA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft opened a new position in Kailera Therapeutics (KLRA) in Q2 2026: 22,951 shares worth $506K. The stake represents ﹤0.01% of the portfolio and ranks #1777 among its holdings.

17 funds tracked by Wall St. Rank hold KLRA as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 22,951 shares of Kailera Therapeutics worth $506K as of Q2 2026.
  • Kailera Therapeutics was a new Universal-Beteiligungs- und Servicegesellschaft position in Q2 2026.
  • Kailera Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1777 holding.
  • 17 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.